Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.73 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.73 |
| ▸ | IDO1 | P14902 | 1/20 | 0.58 |
| ▸ | NSD2 | O96028 | 1/20 | 0.58 |
| ▸ | TDO2 | P48775 | 1/20 | 0.58 |
| ▸ | RET | P07949 | 1/20 | 0.56 |
| ▸ | KDR | P35968 | 1/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.52 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.52 |
| ▸ | TUBB | P07437 | 1/20 | 0.52 |
| ▸ | YES1 | P07947 | 1/20 | 0.52 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.52 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.52 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.52 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.52 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.52 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.52 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.52 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.52 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Garbanzol SCHEMBL29929200 | 1.00 | ESR1 (0.73) | ESR1ESR2IDO1NSD2TDO2 | |
| Garbanzol SCHEMBL9663852 | 1.00 | ESR1 (0.73) | ESR1ESR2IDO1NSD2TDO2 | |
| SCHEMBL28180041 | 0.92 | ESR2 (0.62) | ESR1ESR2IDO1NSD2TDO2 | |
| SCHEMBL2398445 | 0.92 | ESR2 (0.62) | ESR1ESR2IDO1NSD2TDO2 | |
| Fustin SCHEMBL13583362 | 0.88 | IDO1 (0.77) | ESR1ESR2IDO1NSD2TDO2 | |
| Fustin SCHEMBL555237 | 0.88 | IDO1 (0.77) | ESR1ESR2IDO1NSD2TDO2 | |
| Fustin SCHEMBL13640269 | 0.88 | IDO1 (0.77) | ESR1ESR2IDO1NSD2TDO2 | |
| Fustin SCHEMBL29929489 | 0.88 | IDO1 (0.77) | ESR1ESR2IDO1NSD2TDO2 | |
| Fustin SCHEMBL30443589 | 0.88 | IDO1 (0.77) | ESR1ESR2IDO1NSD2TDO2 | |
| SCHEMBL26982934 | 0.88 | SMN1; SMN2 (0.63) | ESR1ESR2IDO1NSD2TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025222309-A1 | FERMENTED PROBIOTIC PROTEIN PLANT BEVERAGE COMPRISING QUINOA AND CHICKPEAS | PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE (CL) | 2025-10-30 | — | — | WO | claimed |
| WO-2025099551-A1 | EDIBLE UTENSILS AND METHOD FOR PRODUCING SAME | Productos Alimenticios Doria S.A.S. (CO) | 2025-05-15 | — | — | WO | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2024138278-A1 | COMPOSITION FOR PRODUCING GLUTEN-FREE DOUGHS AND PASTAS COMPRISING QUINOA FLOUR AND QUINOA LEAF POWDER | PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE (CL) | 2024-07-04 | — | — | WO | claimed |
| WO-2024141685-A1 | PRE-MIX FOR BAKERY AND PASTRY PRODUCTS | PEREYRA NADIA MARCELA (ES) | 2024-07-04 | — | — | WO | claimed |
| WO-2023180805-A1 | POSTBIOTIC FOOD ADDITIVE | IGEN BIOLAB GROUP AG (CH) | 2023-09-28 | — | — | WO | claimed |
| US-20230248755-A1 | COMPOSITIONS FOR IMPROVING JOINT HEALTH | BioRelief, LLC (US) | 2023-08-10 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| US-11234918-B2 | Methods for botanical and/or algae extraction | BASF CORPORATION (US) | 2022-02-01 | — | — | US | claimed |
| US-20260133102-A1 | METHODS FOR DETERMINING THE AMOUNT OF ENCAPSULATED AND FREE IRON IN A SAMPLE | SLOIRON, INC. (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4726633-A1 | COMPETITIVE PRICING ENABLER AND METHOD ASSISTED BY GENERATIVE ARTIFICIAL INTELLIGENCE (GENAI) MODELS | Tata Consultancy Services Limited (IN) | 2026-04-15 | — | — | EP | disclosed |
| US-20260099857-A1 | COMPETITIVE PRICING ENABLER AND METHOD ASSISTED BY GENERATIVE ARTIFICIAL INTELLIGENCE (GenAI) MODELS | TATA CONSULTANCY SERVICES LIMITED (IN) | 2026-04-09 | — | — | US | disclosed |
| WO-2025222309-A1 | FERMENTED PROBIOTIC PROTEIN PLANT BEVERAGE COMPRISING QUINOA AND CHICKPEAS | PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE (CL) | 2025-10-30 | — | — | WO | disclosed |
| WO-2022182220-A1 | NUTRITIONAL SUPPORT SYSTEM FOR ACTIVATING ALTERED METABOLIC PATHWAYS | LEAL MARTINEZ FERNANDO (MX) | 2022-09-01 | — | — | WO | disclosed |
| US-20220211085-A1 | EDIBLE PASTE AND COMPOSITION AND METHOD OF PREPARATION | C-PASTE LIMITED (GB) | 2022-07-07 | — | — | US | disclosed |
| WO-2022056648-A1 | NATURAL SURFACTANTS COMPRISING SOLUBLE NANOCOMPLEXES OF QUINOA PROTEINS/ANIONIC POLYSACCHARIDES (ALGINATE) AND CATIONIC POLYSACCHARIDES (CHITOSAN) FOR USE IN FOODS AND COSMETICS | UNIVERSIDAD DE CHILE (CL) | 2022-03-24 | — | — | WO | disclosed |
| WO-2022058632-A1 | STRAIN OF THE GENUS STREPOMYCES AND USES IN AGRICULTURE | DESARROLLO AGRÍCOLA Y MINERO, S.A. (ES) | 2022-03-24 | — | — | WO | disclosed |
| US-11234918-B2 | Methods for botanical and/or algae extraction | BASF CORPORATION (US) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11234918-B2 | Methods for botanical and/or algae extraction | ALG1, ALG8, CUTA | ESR1 4633/4885ESR2 4170/4885IDO1 2081/4885 |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | ESR1 1524/4885ESR2 409/4885IDO1 4638/4885 |
| US-20260133102-A1 | METHODS FOR DETERMINING THE AMOUNT OF ENCAPSULATED AND FREE IRON IN A SAMPLE | SLC40A1, FECH, TFRC | ESR1 4073/4885ESR2 2869/4885IDO1 2715/4885 |
| US-20230248755-A1 | COMPOSITIONS FOR IMPROVING JOINT HEALTH | TRPV1, CALCB, TRPV2 | ESR1 1363/4885ESR2 618/4885IDO1 2338/4885 |
| US-20260099857-A1 | COMPETITIVE PRICING ENABLER AND METHOD ASSISTED BY GENERATIVE ARTIFICIAL INTELLIGENCE (GenAI) MODELS | TNFRSF1A, RICTOR, CD40 | ESR1 918/4885ESR2 2786/4885IDO1 1322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.